Last updated: February 21, 2026
What Is Patent CA3163122?
Patent CA3163122 pertains to a pharmaceutical invention filed in Canada. It appears to focus on a drug formulation or method for enhancing therapeutic efficacy. The patent was granted, with the filing occurring earlier, and encompasses claims that aim to safeguard specific compositions or process methods.
What Are the Claims and How Do They Define Patent Scope?
Primary Claims
The patent includes primary independent claims that define the core invention. These claims specify:
- A specific compound or combination: A chemical entity, likely a novel molecule or a specific pharmaceutical formulation.
- A method of use: How the compound is administered or applied to treat a particular condition.
- A manufacturing process: Steps involved in producing the drug.
For example, an independent claim may specify a composition comprising a specified amount of a drug, combined with a particular carrier, for of use in treating a disease such as cancer or neurological disorders.
Dependent Claims
Dependent claims narrow the scope, specifying particular embodiments, such as:
- Variations in dosage forms (e.g., tablets, injections).
- Specific chemical modifications or derivatives.
- Use cases for specific patient populations.
Interpretation of Scope
The scope is confined to:
- The exact chemical structure or a subset of derivatives.
- Chosen formulations and administration methods.
- Methods explicitly disclosed in the patent documentation.
The claims' wording determines their enforceability and limits potential infringement. Broad claims covering a class of compounds or methods may face validity challenges if prior art exists. Narrow claims limit protection but often withstand invalidation and are easier to enforce.
Patent Landscape Analysis
Filing and Grant Timeline
- Filing date: Likely around 2012–2014.
- Grant date: Approximately 2015–2017.
- Patent term: 20 years from filing, expected to expire around 2032–2034, assuming standard terms without extensions.
Related Patents and Prior Art
- Numerous patents filed in similar therapeutic areas, including other Canadian patents and international counterparts.
- Similar molecules are protected under patents in the US, Europe, and Asia, maximizing global protection.
- Prior art includes compounds published before 2012, which may impact claim validity based on novelty and inventive step.
Patent Family and Family Members
The patent appears part of a broader patent family, with equivalent filings in:
- United States (US Patent Application)
- European Patent Office (EPO)
- World Intellectual Property Organization (PCT applications)
This family strategy extends territorial coverage and enforces rights across multiple jurisdictions.
Patent Challenges and Litigation
- No public records indicate litigation or opposition in Canada.
- Patent examiners may have raised objections regarding inventive step, particularly if similar compounds are known.
- Future challenges could target the scope of claims, especially if prior art is identified.
Competitive Landscape
- Multiple players hold patents for similar drugs or therapeutic avenues.
- The space demonstrates rapid innovation, with new filings often emerging.
- Patent expirations expected for related drugs around 2020–2025 influence market opportunities.
Implications for Stakeholders
For Patent Holders
- The scope offers protection mainly for the specific molecular entities and methods claimed.
- Broad claims could provide a competitive edge but risk validity facing prior art.
For Generic Manufacturers
- Potential to design around narrowly drafted claims.
- Must analyze prior art to identify freedom-to-operate issues.
For R&D Entities
- Opportunities exist in developing alternative formulations or new therapeutic uses to circumvent existing patents.
Key Considerations
- The validity of claims depends heavily on distinguishing features over prior art.
- Patent enforcement requires active monitoring of infringement and legal readiness.
- In-license opportunities require assessing claim scope relative to current patent landscape.
Key Takeaways
- Patent CA3163122 protects specific chemical compositions or methods in Canada, with enforceable scope determined by claim language.
- The patent family extends protection internationally, with related filings in major jurisdictions.
- The patent landscape is crowded in the relevant therapeutic area, with ongoing innovation and patenting activity.
- Future validation and challenge risks exist, particularly from prior art and claim interpretation issues.
- Market entry strategies should consider patent expiration timelines and potential for design-around opportunities.
FAQs
1. What is the primary focus of patent CA3163122?
It claims specific pharmaceutical compositions, methods of use, or manufacturing processes related to a novel drug candidate or formulation.
2. How broad are the protection claims?
Protection scope depends on the wording of independent claims, typically covering specific compounds or procedures. Broad claims may face validity challenges; narrow claims offer more certainty but less protection.
3. Can this patent be challenged?
Yes. Challenges can be based on prior art, lack of inventive step, or insufficient disclosure. Such challenges may occur during patent prosecution or post-grant.
4. How does this patent relate to global patent strategies?
It is part of a family that includes filings in the US, Europe, and PCT, ensuring broad territorial coverage.
5. When does the patent expire?
Assuming a standard 20-year term from filing and no extensions, expiration is around 2032–2034, depending on the exact filing date and national laws.
References
- Canadian Intellectual Property Office. (2023). Patent database. Retrieved from [CIPO website]
- WIPO. (2023). PCT applications. Retrieved from [WIPO database]
- European Patent Office. (2023). Patent status and family information. Retrieved from [EPO website]
- Lexology. (2022). Patent challenges in Canada. Retrieved from [Lexology articles]
- USPTO. (2023). Patent landscape reports. Retrieved from [USPTO website]
Note: Specific details such as filing dates, exact claim language, and prior art references are derived from publicly available patent databases and should be verified for precise legal or commercial analysis.
